Impact of transcatheter edge to edge repair in functional mitral regurgitation and cardiac resynchronization‐therapy nonresponders
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.31190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Bishoy Abraham und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular disease, Mayo Clinic Hospital, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Cardiac Resynchronization Therapy, Ventricular Function, Left, Recovery of Function. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Despite optimal medical therapy and cardiac resynchronization therapy (CRT), significant functional mitral regurgitation (MR) persisted in 30% of the patients and labeled as CRT nonresponders.
Aims
We sought to study the impact of transcatheter edge‐to‐edge repair (TEER) in patients with symptomatic grade III and IV functional MR despite CRT.
Methods
A retrospective analysis was conducted of all patients who had prior CRT for at least 6 months and underwent TEER for significant residual functional MR (grade ≥3) and symptomatic heart failure (HF) at our institution. The primary outcomes were the change in New York Heart Association classification (NYHA), MR grade, echo parameters, and NT‐ProBNP from baseline to 1‐year post‐procedure.
Results
A total of 28 patients were identified, mean age of 73 ± 6.7 years and 89% males. Procedure success was achieved in all patients. At 1‐year follow‐up, patients had lower MR grade (median 2, IQR 1 [1,2] vs. 4, IQR 1 [3,4]; p < 0.001), NYHA class (median 2, IQR 1 [2,3] vs. 3, IQR 1 [3,4]; p < 0.001), and NT‐ProBNP (7658 ± 11322 vs. 3760 ± 4431; p = 0.035) compared to before the TEER procedure. The left ventricular end‐diastolic volume (255 ± 59 vs. 244 ± 66 mm; p = 0.016) and the right ventricular systolic pressure (52 ± 14 mmHg vs. 37 ± 13 mmHg,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular disease, Mayo Clinic Hospital, Phoenix, Arizona, USA.
- Department of Medicine, Creighton University, Phoenix, Arizona, USA.
- Division of Cardiovascular disease, Willis-Knighton Medical Center, Shreveport, Louisiana, USA.
- Department of Medicine, Rochester Regional Hospital, Rochester, New York, USA.
- Division of Cardiology, Mayo Clinic Hospital, Rochester, Minnesota, USA.
- Department of Cardiovascular Surgery, Mayo Clinic Hospital, Phoenix, Arizona, USA.
ORCID-Profile: Bishoy Abraham
Zitieren
APA
Abraham, B., Suppah, M., Megaly, M., Elbanna, M., Kaldas, S., Alsidawi, S., David Fortuin, F., Sweeney, J., Ayoub, C., Alkhouli, M., Sell-Dottin, K., Chao, C. J., & Arsanjani, R. (2024). Impact of transcatheter edge to edge repair in functional mitral regurgitation and cardiac resynchronization‐therapy nonresponders. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31190
Vancouver
Abraham B, Suppah M, Megaly M, Elbanna M, Kaldas S, Alsidawi S, et al. Impact of transcatheter edge to edge repair in functional mitral regurgitation and cardiac resynchronization‐therapy nonresponders. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31190
BibTeX
@article{Abraham2024,
author = {Abraham, Bishoy and Suppah, Mustafa and Megaly, Michael and Elbanna, Mostafa and Kaldas, Sara and Alsidawi, Said and David Fortuin, F and Sweeney, John and Ayoub, Chadi and Alkhouli, Mohamad and Sell-Dottin, Kristen and Chao, Chieh-Ju and Arsanjani, Reza},
title = {Impact of transcatheter edge to edge repair in functional mitral regurgitation and cardiac resynchronization‐therapy nonresponders},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.31190}
}
EUVIMED